Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Chandra Bhagat PharmaBOM:542934 -4.97%65 Days Payable is 40.77 as of Mar. 2026, which is 45% below its 10-year median of 73.85. GuruFocus rates BOM:542934 with a GF Score™ of 65/100 and a GF Value™ of ₹70.19 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 115 Medical Distribution companies, Chandra Bhagat Pharma ranks worse than 70.43% on this metric.
The historical rank and industry rank for Chandra Bhagat Pharma's Days Payable or its related term are showing as below:
BOM:542934'
s Days Payable Range Over the Past 10 Years
Min: 9.88 Med: 73.85 Max: 89.72
Current: 55.58
During the past 10 years, Chandra Bhagat Pharma's highest Days Payable was 89.72. The lowest was 9.88. And the median was 73.85.
BOM:542934's Days Payable is ranked worse than 70.43% of 115
companies
in the Medical Distribution industry
Industry Median: 79.11
vs BOM:542934: 55.58
Chandra Bhagat Pharma Days Payable Historical Data
* Premium members only.
The historical data trend for Chandra Bhagat Pharma's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:542934 vs MCK, CAH, COR: Days Payable Comparison
For the Medical Distribution subindustry, Chandra Bhagat Pharma's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chandra Bhagat Pharma Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Chandra Bhagat Pharma's Days Payable distribution charts can be found below:
* The bar in red indicates where Chandra Bhagat Pharma's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Chandra Bhagat Pharma's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chandra Bhagat Pharma (BOM:542934) has a Days Payable of 40.77 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Chandra Bhagat Pharma and its competitors. This is 45% below median its historical median of 73.85. Over the past decade, Chandra Bhagat Pharma's Days Payable has ranged from 9.88 to 89.72. According to the industry distribution chart, Chandra Bhagat Pharma ranks #81 out of 115 companies in the Medical Distribution industry, placing it in the top 70.4%.
Is Chandra Bhagat Pharma's Days Payable too high?
Chandra Bhagat Pharma's current Days Payable of 40.77 is 45% below median its 10-year median of 73.85. Over the past 10 years, this metric has ranged from a low of 9.88 to a high of 89.72. The Medical Distribution industry median Days Payable is 79.11. Chandra Bhagat Pharma's value of 40.77 is 48.5% below this industry median. Based on the distribution chart, Chandra Bhagat Pharma ranks #81 out of 115 companies in the Medical Distribution industry, which is below the industry midpoint. Overall, Chandra Bhagat Pharma has a GF Score™ of 65/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Chandra Bhagat Pharma's Days Payable compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Chandra Bhagat Pharma ranks #81 out of 115 companies for Days Payable. This places Chandra Bhagat Pharma in the lower half of its industry. The industry median Days Payable is 79.11. Chandra Bhagat Pharma's value of 40.77 is 48.5% below this benchmark. Historically, Chandra Bhagat Pharma's own Days Payable has ranged from 9.88 to 89.72 over the past decade. While the company's 10-year median is 73.85 vs. the industry median of 79.11, Chandra Bhagat Pharma has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 79.11, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Chandra Bhagat Pharma's current Days Payable of 40.77 is 48.5% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Chandra Bhagat Pharma and its competitors. For the Medical Distribution industry, the median Days Payable is 79.11 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chandra Bhagat Pharma's current Days Payable is 40.77, which is 45% below median its own 10-year median of 73.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chandra Bhagat Pharma stock overvalued right now?
Based on GuruFocus' analysis, Chandra Bhagat Pharma (BOM:542934) is currently considered Possible Value Trap. The stock's GF Value™ is ₹70.19, compared to a current price of ₹33.06 — trading 52.9% below its estimated fair value. The current Days Payable is 40.77, which is 45% below median its 10-year median of 73.85 and 48.5% below the Medical Distribution industry median of 79.11. Chandra Bhagat Pharma's overall GF Score™ is 65/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Chandra Bhagat Pharma (BOM:542934), the current Days Payable is 40.77 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chandra Bhagat Pharma (BOM:542934) Overvalued in 2026?
Based on GuruFocus' analysis, Chandra Bhagat Pharma stock appears to be undervalued.
The current stock price of ₹33.06 is trading 52.9% below its estimated GF Value™ of ₹70.19.
GuruFocus considers Chandra Bhagat Pharma to be Possible Value Trap.
Key valuation signals for BOM:542934:
Days Payable: 40.77 (45% below median its 10-year median of 73.85)
GF Value™: ₹70.19 vs. price of ₹33.06 (52.9% below fair value)
Industry Position: 48.5% below the Medical Distribution median (#81 of 115)
No single metric tells the full story. See the BOM:542934 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Chandra Bhagat Pharma Ltd is a pharmaceutical company marketing pharmaceutical, critical care, and health care products across the globe. The company deals in many categories of pharmaceutical products like anticancer, cardiovascular, anti-infective, etc. It offers various forms of pharmaceutical products, like oral solids. tablets, capsules, liquid orals, syrup suspension, injections, liquid, powder, etc. Additionally, the company is also engaged in promoting and marketing of Active Pharmaceutical Ingredients (API's) in India.
65GF Score
Get the complete analysis for BOM:542934
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542934 has been successfully added to your 
